X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (141) 141
index medicus (122) 122
oncology (88) 88
male (83) 83
middle aged (81) 81
female (80) 80
hematology (78) 78
aged (75) 75
rituximab (69) 69
adult (63) 63
antineoplastic combined chemotherapy protocols - therapeutic use (60) 60
treatment outcome (54) 54
aged, 80 and over (50) 50
article (44) 44
lymphomas (43) 43
chemotherapy (39) 39
cancer (34) 34
non-hodgkins-lymphoma (31) 31
survival (31) 31
hemic and lymphatic diseases (29) 29
abridged index medicus (28) 28
prognosis (28) 28
therapy (28) 28
antineoplastic agents - therapeutic use (27) 27
disease-free survival (27) 27
care and treatment (26) 26
transplantation (24) 24
vincristine - administration & dosage (23) 23
doxorubicin - administration & dosage (22) 22
bortezomib (21) 21
cyclophosphamide - administration & dosage (21) 21
mantle cell lymphoma (21) 21
lymphoma, mantle-cell - drug therapy (20) 20
bendamustine (19) 19
prednisone - administration & dosage (19) 19
antibodies, monoclonal, murine-derived - administration & dosage (18) 18
antineoplastic combined chemotherapy protocols - administration & dosage (18) 18
follicular lymphoma (18) 18
immune system diseases (18) 18
neoplasm staging (18) 18
phase-ii (18) 18
trial (18) 18
antibodies, monoclonal, murine-derived - therapeutic use (17) 17
clinical trials (16) 16
clinical trials as topic (16) 16
immunotherapy (16) 16
lymphoma, large b-cell, diffuse - drug therapy (16) 16
lymphoma, mantle-cell - therapy (16) 16
non-hodgkin-lymphoma (16) 16
plus rituximab (16) 16
progression-free survival (16) 16
research (16) 16
young adult (16) 16
adolescent (15) 15
chronic lymphocytic-leukemia (15) 15
lymphoma (15) 15
lymphoma, mantle-cell - pathology (15) 15
survival rate (15) 15
antineoplastic agents - adverse effects (14) 14
cyclophosphamide (14) 14
doxorubicin - therapeutic use (14) 14
patients (14) 14
analysis (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
doxorubicin (13) 13
expression (13) 13
multicenter (13) 13
recurrence (13) 13
survival analysis (13) 13
vincristine (13) 13
antibodies, monoclonal - therapeutic use (12) 12
antineoplastic agents - administration & dosage (12) 12
b-cell lymphoma (12) 12
drug therapy (12) 12
follow-up studies (12) 12
lymphoma, follicular - drug therapy (12) 12
lymphoma, non-hodgkin - drug therapy (12) 12
non-hodgkin lymphoma (12) 12
vincristine - therapeutic use (12) 12
cyclophosphamide - therapeutic use (11) 11
disease (11) 11
drug administration schedule (11) 11
kaplan-meier estimate (11) 11
lymphoma, mantle-cell - mortality (11) 11
prednisone - therapeutic use (11) 11
r-chop (11) 11
clinical trials and observations (10) 10
combined modality therapy (10) 10
dose-response relationship, drug (10) 10
elderly-patients (10) 10
etoposide - administration & dosage (10) 10
hematology, oncology and palliative medicine (10) 10
hodgkin disease - drug therapy (10) 10
leukemia (10) 10
leukemia, lymphocytic, chronic, b-cell - drug therapy (10) 10
open-label (10) 10
remission induction (10) 10
risk factors (10) 10
antibodies, monoclonal, murine-derived - adverse effects (9) 9
apoptosis (9) 9
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hematology, ISSN 1520-4391, 12/2017, Volume 2017, Issue 1, pp. 358 - 364
Follicular lymphoma is the most common indolent non-Hodgkin lymphoma in the Western hemisphere. The natural history of FL appears to have been favorably... 
How Understanding Disease Biology Is Influencing Clinical Decision-Making | Indolent Lymphoma
Journal Article
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 11/2018, Volume 16, Issue 11, pp. 732 - 734
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 12/2018, Volume 16, Issue 12, p. 776
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 10/2018, Volume 16, Issue 10, p. 634
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 06/2018, Volume 16, Issue 6, p. 396
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 05/2018, Volume 16, Issue 5, p. 304
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 04/2018, Volume 16, Issue 4, p. 234
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 03/2018, Volume 16, Issue 3, p. 159
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 02/2018, Volume 16, Issue 2, p. 74
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 01/2018, Volume 16, Issue 1, p. 6
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 12/2017, Volume 15, Issue 12, p. 892
Journal Article
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 12/2017, Volume 15, Issue 12, p. 892
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 11/2017, Volume 15, Issue 11, p. 806
Journal Article
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 11/2017, Volume 15, Issue 11, p. 806
Journal Article
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 10/2017, Volume 15, Issue 10, p. 722
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 09/2017, Volume 15, Issue 9, p. 651
Journal Article
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 09/2017, Volume 15, Issue 9, p. 651
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 08/2017, Volume 15, Issue 8, p. 567
Journal Article
Clinical advances in hematology & oncology : H&O, ISSN 1543-0790, 08/2017, Volume 15, Issue 8, p. 567
Journal Article
Clinical Advances in Hematology and Oncology, ISSN 1543-0790, 07/2017, Volume 15, Issue 7, p. 502
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.